SAGE - שולי רווח תפעולי Sage Therapeutics

Sage Therapeutics, Inc. (SAGE) revenues are based on the promotion of Zurzuvae and therapies for major depressive disorder in the US. The operating profit margin helps track the actual effectiveness of management, while the -429.90 mark reflects the latest data. Prospects rely on the use of external certified manufacturing capacities and leadership in creating breakthrough neuroactive steroids to transform the treatment of CNS disorders.
SAGE (Sage Therapeutics, Inc.): פילוחים אנליטיים ודוחות לפי אינדיקטורים

To minimize risks during long-term asset ownership, it is critical to track cost management efficiency via the operating margin, which measures the share of profit from core operations before interest and taxes relative to total revenue. The operating margin trend for Sage Therapeutics, Inc. (SAGE) confirms high business resilience, as demand for antidepressants is independent of economic cycles and is covered by insurance.